Video

Mark R. Gilbert Discusses Glioblastoma Research

Author(s):

Mark R. Gilbert

CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

Mark R. Gilbert, senior investigator, chief, Neuro-Oncology Branch, National Cancer Institute, discusses the need for collaboration in glioblastoma research. CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

Related Videos
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Related Content
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.
April 2nd 2025

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

Ryan Scott
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
VXM01, an investigational vaccine, plus Bavencio demonstrated safety and tolerability in recurrent glioblastoma: © stockdevil - stock.adobe.com
March 26th 2025

A VXM01 Vaccine Combination Generates Safe Responses in Glioblastoma

Ryan Scott
Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Illustration of brain.
February 28th 2025

Pregnancy After Glioma Diagnosis Associated With Worse Progression Time

Alex Biese
For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free survival times.